Instruments, consumables, reagents, and various additional services are all part of the global market for Life Sciences Tools. The development of the pharmaceutical, healthcare, and research and development sectors has given the global market for life sciences tools a considerable boost in recent years. Acknowledging this growth, Cells for Cells expanded its Life Science Tools portfolio to help accelerate the drug research and development process and the adoption of advanced technologies, such as in situ bioprinting, in clinical settings.
Life Science Tools
Perhaps one of the most compelling characteristics of the Life Science Tools sector is its faster route to commercialization. Unlike drugs, biologics, and medical devices, most bio-tools follow a simpler, more straightforward approval process. This has led to the formation of several new companies, the acquisition of players by large companies, and the signing of major licensing and co-development deals in the past years. Remarkably, projects related to the Life Science Tools sector provide an exit opportunity that is especially appealing for short- and mid-term investors.
Pipeline
